Načítá se...

Drug targets and predictive biomarkers in the management of metastatic melanoma

Melanoma is the leading cause of fatal skin cancer, and in the past few decades, there has been an increase in the incidence of and mortality from metastatic melanoma. Until recently, the therapeutic options for treatment of metastatic melanoma were limited. The approval of ipilimumab (an anti-CTLA-...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Thumar, Jaykumar, Giesen, Eva, Kluger, Harriet M
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2012
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3513235/
https://ncbi.nlm.nih.gov/pubmed/23226069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S25100
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!